HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human apolipoprotein A-II associates with triglyceride-rich lipoproteins in plasma and impairs their catabolism.

Abstract
Postprandial hypertriglyceridemia and low plasma HDL levels, which are principal features of the metabolic syndrome, are displayed by transgenic mice expressing human apolipoprotein A-II (hapoA-II). In these mice, hypertriglyceridemia results from the inhibition of lipoprotein lipase and hepatic lipase activities by hapoA-II carried on VLDL. This study aimed to determine whether the association of hapoA-II with triglyceride-rich lipoproteins (TRLs) is sufficient to impair their catabolism. To measure plasma TRL residence time, intestinal TRL production was induced by a radioactive oral lipid bolus. Radioactive and total triglyceride (TG) were rapidly cleared in control mice but accumulated in plasma of transgenic mice, in relation to hapoA-II concentration. Similar plasma TG accumulations were measured in transgenic mice with or without endogenous apoA-II expression. HapoA-II (synthesized in liver) was detected in chylomicrons (produced by intestine). The association of hapoA-II with TRL in plasma was further confirmed by the absence of hapoA-II in chylomicrons and VLDL of transgenic mice injected with Triton WR 1339, which prevents apolipoprotein exchanges. We show that the association of hapoA-II with TRL occurs in the circulation and induces postprandial hypertriglyceridemia.
AuthorsSonia Dugué-Pujol, Xavier Rousset, Danièle Pastier, Nhuan Tran Quang, Virginie Pautre, Jean Chambaz, Michèle Chabert, Athina-Despina Kalopissis
JournalJournal of lipid research (J Lipid Res) Vol. 47 Issue 12 Pg. 2631-9 (Dec 2006) ISSN: 0022-2275 [Print] United States
PMID16990646 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoprotein A-II
  • Chylomicrons
  • Lipoproteins
  • Lipoproteins, VLDL
  • Recombinant Proteins
  • Triglycerides
Topics
  • Animals
  • Apolipoprotein A-II (blood, deficiency, genetics)
  • Chylomicrons (metabolism)
  • Female
  • Humans
  • Hyperglycemia (blood, etiology)
  • Intestinal Mucosa (metabolism)
  • Lipoproteins (blood)
  • Lipoproteins, VLDL (blood)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Recombinant Proteins (blood, genetics)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: